CTRI/2024/02/062899招募中Unknown
Efficacy and safety of levodopa in dystonia due to neurological Wilson disease, an open labeled placebo controlled randomized controlled trial
Dr Jayantee Kalita0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Baseline 4 weeks. Age more than 8 years, BFMDR score more than 10. Baseline blood investigation followed by 1: 1 randomization. Levodopa Titration for 2 weeks and maintained for 12 weeks
排除标准
- •Patients with head injury, stroke, tumor, malignancy, chronic renal failure, decompensated liver disease, perinatal hypoxia, HIV, organ transplantation, pregnancy and those receiving antipsychotics, corticosteroid, antiemetic and structural brain lesion on MRI not explainable by WD will be excluded.
研究者
相似试验
招募中
Unknown
ow-dose L-DOPA treatment for drug-induced dystoniaDrug-induced dystoniaJPRN-UMIN000054201Osaka Neurological Institute9
招募中
不适用
Pathophysiology of L-Dopa responsive Dystonia and other monogenetic disordersDRKS00019110Zentrum für Kinder-und Jugendmedizin Heidelberg Sektion für Neuropädiatrie und Stoffwechselmedizin50
招募中
Unknown
Does levodopa/carbidopa, a common Parkinson's Disease drug, affect stomach emptying, blood pressure and heart rate?Postprandial hypotensionDelayed gastric emptyingOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonCardiovascular - Diseases of the vasculature and circulation including the lymphatic systemMetabolic and Endocrine - Other metabolic disordersNeurological - Parkinson's diseaseCardiovascular - Other cardiovascular diseasesParkinson's diseaseACTRN12624001010583Professor Karen Jones, The University of Adelaide20
尚未招募
4 期
Evaluating the efficacy and safety of (Embella®) in management of superficial lipomassuperficial lipoma.Benign lipomatous neoplasmIRCT20240416061507N2Espad pharmed10
尚未招募
4 期
The efficacy and safety of Deoxycholic acid injection in reduction of flank fatFlank fat.Localized adiposityIRCT20240416061507N1Espad Pharmed Co30